CervoMed Announces Publication in Neurology® Results Showing a Blood Test at Study Entry Identified Patients Who Demonstrated Substantial Response to Neflamapimod in Dementia with Lewy Bodies : vimarsana.com

CervoMed Announces Publication in Neurology® Results Showing a Blood Test at Study Entry Identified Patients Who Demonstrated Substantial Response to Neflamapimod in Dementia with Lewy Bodies

/PRNewswire/ -- CervoMed Inc., a clinical stage company focused on developing treatments for degenerative diseases of the brain, today announced the...

Related Keywords

Massachusetts , United States , Boston , American , John Alam , Stephen Gomperts , Prnewswire Cervomed Inc , Diffusion Pharmaceuticals Inc , Linkedin , Cervomed Inc , Pharma Inc , Twitter , Drug Administration , American Academy Of Neurology , International Shopping List Test , Nature Communications , Med Inc , American Academy , Lewy Bodies , Lewy Body Dementia , Massachusetts General Hospital , Chief Executive Officer , Study Results , Mixed Models , Repeated Measures , Clinical Dementia Rating Scale Sum , International Shopping List Test Recognition , Fast Track , National Institutes , National Institute , Diffusion Pharmaceuticals , Health Care Amp Hospitals , Medical Pharmaceuticals , Biotechnology , Clinical Trials Amp Medical Discoveries ,